Free Trial

IBEX (IBEX) Competitors

IBEX logo
$28.76 +0.05 (+0.16%)
As of 12:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IBEX vs. GB, DFIN, CTOS, DGNX, FLYW, CRTO, WLDN, ASTH, PRG, and UPBD

Should you be buying IBEX stock or one of its competitors? The main competitors of IBEX include Global Blue Group (GB), Donnelley Financial Solutions (DFIN), Custom Truck One Source (CTOS), Diginex (DGNX), Flywire (FLYW), Criteo (CRTO), Willdan Group (WLDN), Astrana Health (ASTH), Aaron's (PRG), and Upbound Group (UPBD). These companies are all part of the "business services" industry.

IBEX vs. Its Competitors

Global Blue Group (NYSE:GB) and IBEX (NASDAQ:IBEX) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

Global Blue Group has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500. Comparatively, IBEX has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500.

Global Blue Group has higher revenue and earnings than IBEX. IBEX is trading at a lower price-to-earnings ratio than Global Blue Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Blue Group$545.29M2.74$90.58M$0.3720.23
IBEX$508.57M0.76$33.65M$2.2912.56

In the previous week, IBEX had 3 more articles in the media than Global Blue Group. MarketBeat recorded 4 mentions for IBEX and 1 mentions for Global Blue Group. IBEX's average media sentiment score of 0.42 beat Global Blue Group's score of -0.71 indicating that IBEX is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Global Blue Group
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative
IBEX
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Global Blue Group presently has a consensus target price of $6.00, suggesting a potential downside of 19.84%. IBEX has a consensus target price of $27.00, suggesting a potential downside of 6.10%. Given IBEX's higher probable upside, analysts clearly believe IBEX is more favorable than Global Blue Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Blue Group
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
IBEX
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

89.7% of Global Blue Group shares are owned by institutional investors. Comparatively, 81.2% of IBEX shares are owned by institutional investors. 6.7% of IBEX shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Global Blue Group has a net margin of 16.56% compared to IBEX's net margin of 6.93%. Global Blue Group's return on equity of 45.20% beat IBEX's return on equity.

Company Net Margins Return on Equity Return on Assets
Global Blue Group16.56% 45.20% 4.69%
IBEX 6.93%25.51%12.67%

Summary

Global Blue Group and IBEX tied by winning 7 of the 14 factors compared between the two stocks.

Get IBEX News Delivered to You Automatically

Sign up to receive the latest news and ratings for IBEX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IBEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IBEX vs. The Competition

MetricIBEXBUSINESS SVCS IndustryBusiness SectorNASDAQ Exchange
Market Cap$384.70M$5.95B$22.36B$9.79B
Dividend YieldN/A3.41%2.84%4.13%
P/E Ratio12.5629.3428.3425.07
Price / Sales0.761.8942.03102.38
Price / Cash8.8616.2526.5228.01
Price / Book2.994.976.405.82
Net Income$33.65M$158.88M$200.56M$265.14M
7 Day Performance3.10%2.91%0.25%0.67%
1 Month Performance-1.02%1.94%-2.64%1.83%
1 Year Performance87.94%58.17%38.39%27.21%

IBEX Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IBEX
IBEX
1.4749 of 5 stars
$28.76
+0.2%
$27.00
-6.1%
+85.8%$384.70M$508.57M12.5630,000Positive News
GB
Global Blue Group
1.7284 of 5 stars
$7.38
-0.1%
$6.00
-18.6%
+58.0%$1.47B$545.29M19.932,160High Trading Volume
DFIN
Donnelley Financial Solutions
2.94 of 5 stars
$52.28
+2.4%
$71.33
+36.4%
-17.4%$1.41B$781.90M18.471,800Positive News
CTOS
Custom Truck One Source
1.6767 of 5 stars
$6.01
-2.5%
$6.67
+11.0%
+36.6%$1.39B$1.80B-37.531,800
DGNX
Diginex
N/A$52.59
-5.8%
N/AN/A$1.28BN/A0.0021
FLYW
Flywire
2.7888 of 5 stars
$10.33
-0.4%
$14.77
+43.0%
-35.2%$1.26B$492.14M258.251,250Trending News
Earnings Report
Analyst Upgrade
CRTO
Criteo
4.1396 of 5 stars
$23.12
-1.6%
$40.00
+73.0%
-51.3%$1.25B$1.93B9.673,507
WLDN
Willdan Group
3.5677 of 5 stars
$89.45
+6.5%
$56.00
-37.4%
+214.6%$1.22B$565.80M52.931,761
ASTH
Astrana Health
3.0984 of 5 stars
$21.88
+1.4%
$53.29
+143.5%
-40.1%$1.21B$2.03B30.391,900Earnings Report
PRG
Aaron's
4.3688 of 5 stars
$31.04
+1.8%
$41.00
+32.1%
-20.2%$1.21B$2.46B6.131,403Dividend Announcement
UPBD
Upbound Group
4.34 of 5 stars
$21.23
+2.5%
$34.50
+62.5%
-33.6%$1.20B$4.32B11.9311,970Analyst Downgrade

Related Companies and Tools


This page (NASDAQ:IBEX) was last updated on 8/12/2025 by MarketBeat.com Staff
From Our Partners